Ofer Sharon

458 total citations
8 papers, 346 citations indexed

About

Ofer Sharon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Ofer Sharon has authored 8 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Epidemiology. Recurrent topics in Ofer Sharon's work include Diabetes Treatment and Management (2 papers), Lung Cancer Research Studies (2 papers) and Diabetes Management and Research (2 papers). Ofer Sharon is often cited by papers focused on Diabetes Treatment and Management (2 papers), Lung Cancer Research Studies (2 papers) and Diabetes Management and Research (2 papers). Ofer Sharon collaborates with scholars based in Israel, United States and Belgium. Ofer Sharon's co-authors include Pierre Van Damme, Yotam Levin, Marie Van der Wielen, Sarah Brenner, Varda Shalev, Gabriel Chodick, Harvey L. Katzeff, Inbal Goldshtein, Kimberly G. Brodovicz and Kaan Tunceli and has published in prestigious journals such as Journal of Clinical Oncology, Vaccine and Journal for ImmunoTherapy of Cancer.

In The Last Decade

Ofer Sharon

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ofer Sharon Israel 6 187 119 118 58 53 8 346
Jana Zeitvogel Germany 11 17 0.1× 173 1.5× 148 1.3× 37 0.6× 57 1.1× 17 317
Amélie Liou France 5 33 0.2× 77 0.6× 23 0.2× 276 4.8× 40 0.8× 7 500
Amylynne Frankel United States 10 20 0.1× 172 1.4× 50 0.4× 92 1.6× 33 0.6× 14 313
William D. Stewart Canada 9 22 0.1× 101 0.8× 101 0.9× 43 0.7× 70 1.3× 30 300
Nathalie Saint-Lu France 8 16 0.1× 147 1.2× 155 1.3× 10 0.2× 52 1.0× 10 581
Ragna H. Thorleifsdottir Iceland 9 7 0.0× 214 1.8× 318 2.7× 17 0.3× 43 0.8× 9 415
Chrysovalantis Korfitis Greece 10 6 0.0× 189 1.6× 114 1.0× 91 1.6× 17 0.3× 19 273
Hong Liao China 9 3 0.0× 93 0.8× 71 0.6× 45 0.8× 107 2.0× 21 352
Pedro Rodríguez‐Jiménez Spain 10 3 0.0× 94 0.8× 64 0.5× 71 1.2× 41 0.8× 46 294
Roberto Morese Italy 6 7 0.0× 127 1.1× 38 0.3× 161 2.8× 82 1.5× 14 380

Countries citing papers authored by Ofer Sharon

Since Specialization
Citations

This map shows the geographic impact of Ofer Sharon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofer Sharon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofer Sharon more than expected).

Fields of papers citing papers by Ofer Sharon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ofer Sharon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofer Sharon. The network helps show where Ofer Sharon may publish in the future.

Co-authorship network of co-authors of Ofer Sharon

This figure shows the co-authorship network connecting the top 25 collaborators of Ofer Sharon. A scholar is included among the top collaborators of Ofer Sharon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ofer Sharon. Ofer Sharon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Harel, Michal, Iris Kamer, Alona Zer, et al.. (2022). Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade. Journal for ImmunoTherapy of Cancer. 10(6). e004582–e004582. 25 indexed citations
2.
Shaked, Yuval, Michal Harel, Ofer Sharon, et al.. (2021). Integration of proteomic and clinical data for the prediction of response to immune checkpoint inhibitor therapy in non-small cell lung cancer.. Journal of Clinical Oncology. 39(15_suppl). e21110–e21110. 2 indexed citations
3.
Bash, Lori D., Dahlia Weitzman, Robert O. Blaustein, et al.. (2017). Comprehensive healthcare resource use among newly diagnosed congestive heart failure. Israel Journal of Health Policy Research. 6(1). 26–26. 10 indexed citations
4.
Goldshtein, Inbal, Avraham Karasik, Cheli Melzer Cohen, et al.. (2016). Urinary albumin excretion with sitagliptin compared to sulfonylurea as add on to metformin in type 2 diabetes patients with albuminuria: A real-world evidence study. Journal of Diabetes and its Complications. 30(7). 1354–1359. 18 indexed citations
5.
Tunceli, Kaan, Inbal Goldshtein, Shengsheng Yu, et al.. (2015). Adherence to treatment guidelines in Type 2 diabetes patients failing metformin monotherapy in a real-world setting. Diabetes Management. 5(1). 17–24. 8 indexed citations
6.
Yu, Jingbo, Inbal Goldshtein, Varda Shalev, et al.. (2015). Renal impairment among postmenopausal women with osteoporosis from a large health plan in Israel. Archives of Osteoporosis. 10(1). 210–210. 2 indexed citations
7.
Damme, Pierre Van, et al.. (2008). Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine. 27(3). 454–459. 255 indexed citations
8.
Brenner, Sarah, et al.. (2002). Pemphigus and infections. Clinics in Dermatology. 20(2). 114–118. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026